Cargando…
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study
BACKGROUND: Peroxisome proliferator-activated receptors (PPARs) play key roles in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). AIM: to assess the effect of functional single nucleotide polymorphisms (SNPs) of PPARα and PPARγ2, previously associated with insulin resistance and dyslip...
Autores principales: | Dongiovanni, Paola, Rametta, Raffaela, Fracanzani, Anna Ludovica, Benedan, Luca, Borroni, Vittorio, Maggioni, Paolo, Maggioni, Marco, Fargion, Silvia, Valenti, Luca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944335/ https://www.ncbi.nlm.nih.gov/pubmed/20825652 http://dx.doi.org/10.1186/1471-230X-10-102 |
Ejemplares similares
-
High Fat Diet Subverts Hepatocellular Iron Uptake Determining Dysmetabolic Iron Overload
por: Dongiovanni, Paola, et al.
Publicado: (2015) -
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2012) -
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls
por: Valenti, Luca, et al.
Publicado: (2012) -
Risk of Obstructive Sleep Apnea with Daytime Sleepiness Is Associated with Liver Damage in Non-Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Pulixi, Edoardo Alessandro, et al.
Publicado: (2014) -
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)